Current status and perspectives of neuroprotection in ischemic stroke treatment.
about
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled TrialsRNA based antagonist of NMDA receptorsCerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral arteryNeuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat.The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion.Investigation of Pathogenesis of H1N1 Influenza Virus and Swine Streptococcus suis Serotype 2 Co-Infection in Pigs by Microarray Analysis.Minocycline for short-term neuroprotectionPreclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration.A rat's whiskers point the way toward a novel stimulus-dependent, protective stroke therapy.Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia.Recombinant human erythropoietin increases cerebral cortical width index and neurogenesis following ischemic stroke.Oxygen glucose deprivation model of cerebral stroke in PC-12 cells: glucose as a limiting factor.Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats.Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
P2860
Q28583917-B66E8BF9-CC1D-41C1-80CD-3D518F7D592DQ33809873-048F33E8-296C-415E-B465-1BB470730AEDQ33918208-2FDF972F-1E23-4CB6-A50E-22FF30321C04Q34480959-F15F8106-456A-47C6-8F44-7068B097FD8AQ34525131-C8092FC7-A581-46F5-88CF-E6E3494FDFB4Q35076749-3D78C3F4-DB40-4C4B-B4E0-A43871A08895Q35612870-F0E530AC-AD25-4B8E-BFC6-FEBEB825EDBFQ36428406-29FA6304-4B83-4E21-B9AC-586235C0A1F9Q36609957-5EE74A8B-43F1-43C7-A363-4E469A7FE863Q37008310-4897A981-68F2-4831-AA54-05A4F6A80763Q38202292-AC44DE4D-4AC0-4B93-81CC-2E8263761FCEQ41991979-4E5C838A-1F5E-40A8-BE37-91FAF9217EA4Q43271959-5D5EAFD4-1FD2-43F3-B68D-D4748ED54E17Q44512034-E20C7699-38DD-4E01-88F3-FA129A6A245DQ46366285-CA6AB52A-3C63-4C67-B1B6-4089CB70BDB9
P2860
Current status and perspectives of neuroprotection in ischemic stroke treatment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Current status and perspectives of neuroprotection in ischemic stroke treatment.
@ast
Current status and perspectives of neuroprotection in ischemic stroke treatment.
@en
type
label
Current status and perspectives of neuroprotection in ischemic stroke treatment.
@ast
Current status and perspectives of neuroprotection in ischemic stroke treatment.
@en
prefLabel
Current status and perspectives of neuroprotection in ischemic stroke treatment.
@ast
Current status and perspectives of neuroprotection in ischemic stroke treatment.
@en
P356
P1476
Current status and perspectives of neuroprotection in ischemic stroke treatment.
@en
P2093
Martínez-Vila E
P356
10.1159/000049127
P478
11 Suppl 1
P577
2001-01-01T00:00:00Z